Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Genistein
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Humanetics
Deal Size : Undisclosed
Deal Type : Partnership
Details : Partnership will support clinical trial studies of BIO 300 in COVID-19 patients.
Brand Name : BIO 300
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 19, 2020
Lead Product(s) : Genistein
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Humanetics
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?